Glucagon is a counter-regulatory hormone that is classically used to treat
hypoglycemia. However, it can elicit the generation of cAMP within the myoc
ardium to cause positive inotropic and chronotropic effects without the nee
d for beta-1 adrenoceptor stimulation. Glucagon has been used extensively t
o treat beta-blocker overdose and has evidence for use has been used as adj
unctive therapy in shock situations and heart failure but is inferior to ca
techolamines. An interesting potential indication for glucagon is in treati
ng post-countershock asystole. (C) 1999 the American College of Clinical Ph
armacology.